Future studies will be needed to determine whether using a higher Ki67 cut point, as well as including additional tumor features, such as PR > 10% or low tumor grade, could increase concordance and also identify a greater proportion of patients who could avoid RS testing. This evidence concerns the gene MKI67 and neoplasm.